Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 12 results:
Author Title [ Type(Desc)] Year
Filters: Author is Price, D. B.  [Clear All Filters]
Journal Article
K. Kostikas, Rhee, C. K., Hurst, J. R., Agostoni, P., Cao, H., Fogel, R., Jones, R., Kocks, J. W. H., Mezzi, K., S. Ming, W. Yau, Ryan, R., and Price, D. B., Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study, Pragmat Obs Res, vol. 11, pp. 55-66, 2020.
D. B. Price, Trudo, F., Voorham, J., Xu, X., Kerkhof, M., J. Jie, L. Zhi, and Tran, T. N., Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study, J Asthma Allergy, vol. 11, pp. 193-204, 2018.
S. W. Turner, Murray, C., Thomas, M., Burden, A., and Price, D. B., Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study, NPJ Prim Care Respir Med, vol. 28, p. 28, 2018.
M. Kerkhof, Tran, T. N., van den Berge, M., Brusselle, G. G., Gopalan, G., Jones, R. C. M., Kocks, J. W. H., Menzies-Gow, A., Nuevo, J., Pavord, I. D., Rastogi, S., and Price, D. B., Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study, PLoS One, vol. 13, p. e0201143, 2018.
M. Kerkhof, Voorham, J., Dorinsky, P., Cabrera, C., Darken, P., Kocks, J. W., Sadatsafavi, M., Sin, D. D., Carter, V., and Price, D. B., Association between COPD exacerbations and lung function decline during maintenance therapy, Thorax, 2020.
J. Dollerup, Vestbo, J., Murray-Thomas, T., Kaplan, A., Martin, R. J., Pizzichini, E., Pizzichini, M. M. M., Burden, A., Martin, J., and Price, D. B., Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study, Clin Epidemiol, vol. 9, pp. 231-243, 2017.
C. S. Murray, Thomas, M., Richardson, K., Price, D. B., and Turner, S. W., Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study, J Allergy Clin Immunol Pract, vol. 5, pp. 1082-1090.e7, 2017.
D. B. Price, Carter, V., Martin, J., Gardener, E. A., Skinner, D., Yang, S., Hoffman, M., Willis, J. C., and Cooper, A. J., Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care, Drugs, 2019.
M. Kerkhof, Tran, T. N., Soriano, J. B., Golam, S., Gibson, D., Hillyer, E. V., and Price, D. B., Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population, Thorax, vol. 73, pp. 116-124, 2018.
J. Voorham, Xu, X., Price, D. B., Golam, S., Davis, J., J. Ling, Z. Jie, Kerkhof, M., Ow, M., and Tran, T. N., Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma, Allergy, vol. 74, pp. 273-283, 2019.
S. Turner, Richardson, K., Murray, C., Thomas, M., Hillyer, E. V., Burden, A., and Price, D. B., Long-Acting beta-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids, J Allergy Clin Immunol Pract, vol. 5, pp. 99-106.e3, 2017.
J. Voorham, Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., Bjermer, L., Miravitlles, M., and Price, D. B., Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK, BMJ Open, vol. 8, p. e022051, 2018.
[Page last reviewed 4 March 2021]